SEC Form 4 · accession 0001209191-18-031200
Aclaris Therapeutics, Inc. · ACRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Kenneth William Powell
Director
Period of report
May 16, 2018
Accepted (ET)
May 17, 2018 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 16, 2018 | P | 500 | $19.12 | A | 500 | D |
Table II — derivative securities
No Table II lines on this filing.